key: cord-0683311-9wohqawi
authors: Aslam, Anoshe; Singh, Jessica; Robilotti, Elizabeth; Chow, Karin; Bist, Tarun; Reidy-Lagunes, Diane; Shah, Monika; Korenstein, Deborah; Babady, N Esther; Kamboj, Mini
title: SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies
date: 2020-10-22
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1607
sha: 1fd937cab4c5596b6a0772b0f79c0fa2608c6d8d
doc_id: 683311
cord_uid: 9wohqawi

BACKGROUND: New York City (NYC) experienced a surge of COVID-19 cases in March and April 2020. Since then, universal PCR based surveillance testing and PPE measures are in wide use in procedural settings. There is limited published experience on the utility and sustainability of PCR based surveillance testing in areas with receding and consistently low community COVID-19 rates. METHODS: The study was conducted at a tertiary care cancer center in NYC from March 22, 2020, until August 22, 2020. Asymptomatic patients underwent SARS CoV-2 testing before surgeries, interventional radiology procedures, and endoscopy. Contact tracing in procedural areas was done if a patient with an initial negative screen re-tested positive within 48 hours of the procedure. RESULTS: From March 22 until August 22, 2020, 11,540 unique patients underwent 14,233 tests before surgeries or procedures at MSKCC. Overall, 65 patients were positive, with a peak rate of 4.3% that fell below 0.3 % after April 2020. For the 65 positive cases, three were pre-symptomatic, and 38 were asymptomatic. Among asymptomatic test-positive patients, 76 % had PCR cycle threshold (Ct) > 30 at first detection. Five patients tested newly positive in the immediate post-operative period, exposing 82 employees with one case of probable transmission (1.2%). CONCLUSION: The prevalence of SARS-CoV-2 infection identified on pre-procedural surveillance was low in our study, which was conducted in an area with limited community spread at the later stage of the study Universal PPE is protective in procedural settings. Optimal and flexible diagnostic strategies are needed to accomplish and sustain the goals of comprehensive pre-procedure surveillance testing.

Procedural areas are high-risk settings for exposure to unrecognized cases of Severe Acute Respiratory Syndrome Coronavirus -2 (SARS CoV-2) infections (1) . In regions with rising community spread, there is a higher likelihood of pre-symptomatic individuals or those with mild coronavirus disease 2019 (COVID- 19) presenting for surgery and other interventions (2, 3) . Several professional societies endorse testing for SARS CoV-2 before surgery and other invasive procedures to reduce the risk of transmission to healthcare workers and avoid postsurgical complications from COVID-19 in patients (4) . Because false-negatives may occur with testing, CDC recommends universal Personal Protective Equipment (PPE) measures, including use of N95 masks for aerosol-generating procedures (AGPs) in places with medium to high community transmission (4) (5) (6) (7) (8) . The guidelines are less clear about surveillance testing strategies when the regional prevalence of SARS-CoV-2 subsides.

On March 1, 2020, New York City (NYC) confirmed the first case of coronavirus disease 2019 (COVID-19). The regional epidemic peaked in mid-April, and, since then, the city has witnessed a sustained daily low case count through the phased reopening (9). By March 10, 2020, Memorial Sloan Kettering Cancer Center (MSKCC), a cancer center located in New York City, had developed polymerase chain reaction (PCR) testing for COVID-19. On March 22, pre-procedure testing was implemented for patients before all procedures: major surgery, interventional radiology procedures, and endoscopy.

This report summarizes a single center experience with pre-procedure testing as the COVID-19 epidemic evolved in NYC. We also describe a series of exposure events to healthcare workers (HCWs) originating from patients who underwent a procedure after testing negative by SARS CoV-2 PCR and who were later found to have laboratory-confirmed SARS-CoV-2 infection within two days after the procedure.

A c c e p t e d M a n u s c r i p t 4

MSKCC is a tertiary care cancer center with 42 operating rooms (OR) and 14 interventional radiology (IR) procedure rooms across the metropolitan area, including NYC, New Jersey, and Westchester County, NY.

SARS CoV-2 PCR testing was done within 48 to 72 hours of the scheduled surgery, interventional radiology procedures, or endoscopy (collectively referred to as procedures).

Those without viral detection underwent further symptom screening on the day of procedure assessing for COVID-19 like symptoms and recent contact with laboratory-confirmed cases.

For patients who tested positive, postponement of non-urgent procedures was as per clinician's discretion regardless of COVID-19 symptoms. Urgent procedures proceeded with the CDC recommended precautions. All non-hospitalized patients who tested positive were followed daily by a dedicated COVID Cohort Management Team (CCMT) as described elsewhere (10) . CCMT monitoring continued until 14 days had elapsed since the last positive test, and the patient remained symptom-free or until clinical resolution of symptoms for at least three days. Data on symptoms over the follow-up period was extracted from CCMT or hospital medical records. Patients were classified as follows: 1) "pre-symptomatic" were clinically well at the positive test time but subsequently developed signs and symptoms of COVID-19; 2) "symptomatic" had symptoms at the time of the positive test; 3) "asymptomatic" patients had no compatible symptoms or illness at the time of the positive result or in subsequent 14-day follow-up period."

Contact investigation proceeded as follows: Index patients identified by PCR testing were investigated for their location at the time of test collection, symptoms and onset date, roommates, and HCW who provided direct care. All exposed individuals received an e-mail notification to complete a post-exposure survey that determined their level of risk based on use of PPE , duration, and intensity of exposure, as defined by the Centers for Disease Control and Prevention (CDC) (8) . The recommendation for surveillance testing for A c c e p t e d M a n u s c r i p t 5 significant exposures was after 5-7 days and 14 days following the index event. Independent of contact tracing efforts, this survey was also completed by any employee for self-reported exposures in the community or to co-workers. All symptomatic employees underwent testing immediately regardless of the intensity of or time post exposure.

Universal PPE at the center included masks for all clinical care activities starting March 20, 2020, with the addition of face shields on April 22, 2020. N95 respirators were used for all AGPs (7) . Beginning on April 13, all hospitalized patients also underwent surveillance testing every three days. proportional to the amount of target viral RNA in the PCR reaction. As the difference between the Ct values for the two targets in each assay and between all three tests were small (within ± 1-2 Ct; data not shown), Ct value analysis were focused on one target (Target 1: N1, N or ORF).

SARS-CoV-2 IgG were measured using the Abbott Architect SARS-CoV-2 IgG (Abbott Laboratories, Abbott Park, IL) an EUA cleared, automated, qualitative, chemiluminescent, A c c e p t e d M a n u s c r i p t 6 microparticle immunoassay on the Architect platform (12) . The assay targets the nucleocapsid protein of SARS-CoV-2 to detect IgG in serum and plasma samples.

Cycle threshold values by groups were reported as means with standard deviation. The

Mann-Whitney-Wilcoxon test was used to estimate the median difference between the symptomatic and asymptomatic test positive patients.

The MSKCC Institutional Review Board granted a Health Insurance Portability and Accountability Act waiver of authorization to conduct this study. 

Amongst 11,475 patients with an initial negative pre-procedure test, five (.04%) subsequently tested positive in the immediate post-operative period (day 0 to day 2). All were in the pre-symptomatic (n=1) or symptomatic (n=4) phase of the illness. One expired within four days of diagnosis and the other four recovered uneventfully. Table 1 Among the four HCWs who were positive, one was symptomatic before the exposure occurred. Two newly positive employees had completed the survey due to other significant unprotected HCW to HCW exposures. A detailed risk assessment showed that both, a nurse in the recovery area room and a radiology technician, had followed universal PPE guidance during the patient encounter, but had extended unprotected contact during a HCW to HCW interaction; the latter was considered the probable transmission event. One patient care technician with limited contact to an unmasked index patient during the pre-operative assessment, and with no other known high-risk activities occupational or community-based No incident cases of SARS COV-2 were diagnosed in any of the other exposed employees regardless of the monitoring period. Overall, we suspect that 1 out of 82 exposed HCWs developed COVID-19 due to patient exposure (1.2%).

As the COVID-19 epidemic evolved in NYC between March and August, the overall risk gradient of pre-procedural SARS CoV-2 positivity was 4.3% at the height of the pandemic Our findings on the low transmission risk to HCW are similar to observations from other US medical centers where transmission from patients to HCW is only reported after extended contact and inadequate PPE (13, 14) . Among the 82 employees exposed to the five patients, testing hinged upon completion of a risk assessment survey, 67% of exposed healthcare exposed workers in our study completed the evaluation, 59% received testing.

The only healthcare worker with a probable transmission was in close contact with the index case when obtaining vital signs, during which the patient was not wearing a mask. Despite exposure to aerosolizing procedures, none subsequently developed an infection.

Pre-procedural testing for SARS-CoV-2 is universally applied in areas with substantial community transmission with short term postponement of surgery for those that test positive. There are several limitations to our study. For pre-procedural testing, the combined interpretation of PCR results with cycle threshold value, presence of symptoms, past illness, and antibody status may be more informative in these scenarios to infer infectivity and acute vs. convalescent phases of infection. Viral culture is the current gold standard to infer infectiousness but not readily accessible or safe for routine use. We based many of our study findings on cycle threshold values, which are not standardized across assays and have substantial inter-assay variability. Cycle threshold is a useful estimate of viral RNA in clinical practice (21) , with low Ct a good proxy for infectivity when interpreted in conjunction with other relevant clinical and laboratory data (22) (23) (24) (25) . Our study is derived from a single specialized center in New York City, and the findings may not be generalizable. Disparities in infection rates within the same geographic area are essential considerations when devising local test strategies.

For contact investigation, only 59% of exposed employees accepted testing for contact investigation, but we followed all exposed for symptomatic illness. We may have possibly missed transmission events that resulted in mild or asymptomatic infections where HCW were either tested too early or not tested. The risk assessment that guided testing was based on self-reported symptoms, and PPE adherence was not measured. The desire for immediate testing may have influenced employee responses to the survey.

This report adds to the literature that PPE substantially mitigates the risk of COVID-19 transmission from unrecognized contagious cases in procedural settings. Healthcare centers should reexamine the utility of widespread pre-surgical SARS Cov-2 testing with PCR assays when background infection rates are low. It is vital to devise and invest in nimble and alternative surveillance test strategies that can quickly adapt to the scale of local community spread and are easy to interpret in all settings. M a n u s c r i p t 15 Table and Figure legends   Table 1 . Case characteristics of five index patients who tested positive for SARS CoV-2 in the immediate post-operative period (48h) after an initial negative pre-procedure test. The number of exposed and tested healthcare workers is shown with one case of probable transmission * Table 1 . Case characteristics of five index patients who tested positive for SARS CoV-2 in the immediate post-operative period (48h) after an initial negative pre-procedure test. The number of exposed and tested healthcare workers is shown with one case of probable transmission * 

Unexpected Fatality in Perioperative Period

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility -King County

Joint Statement: Roadmap for Maintaining Essential Surgery during COVID-19 Pandemic

False Negative Tests for SARS

Infection -Challenges and Implications

The Use of Personal Protective Equipment by Anesthesia Professionals during the COVID-19 Pandemic

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic

Interim Operational Considerations for Public Health Management of

Healthcare Workers Exposed to or with Suspected or Confirmed COVID-19: non

When a Cancer Patient Tests Positive for Covid-19

Determinants of COVID-19 disease severity in patients with cancer

SARS-CoV-2 IgG for Architect Package Insert

COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19

Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient

Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon

Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Evaluation of rapid antigen test for detection of SARS-CoV-2 virus

Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs

Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity? Clin Infect Dis

Predicting infectious SARS-CoV-2 from diagnostic samples

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100

A c c e p t e d M a n u s c r i p t 13 Healthcare Settings. https://wwwcdcgov/coronavirus/2019-ncov/hcp/non-us-settings/publichealth-management-hcw-exposedhtml. 2020.

New York City Department of Health COVID 19